相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The up-regulation of markers of adipose tissue fibrosis by visfatin in pre-adipocytes as well as obese children and adolescents
Samira Ezzati-Mobaser et al.
CYTOKINE (2020)
Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders
Ali Dakroub et al.
CELLS (2020)
Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements
B. Kumari et al.
CURRENT MOLECULAR MEDICINE (2018)
Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus
Panayoula C. Tsiotra et al.
PEPTIDES (2018)
Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients
Chien-Yi Hsu et al.
AMERICAN JOURNAL OF HYPERTENSION (2016)
Endothelial NLRP3 Inflammasome Activation and Enhanced Neointima Formation in Mice by Adipokine Visfatin
Min Xia et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
FK866, a Visfatin Inhibitor, Protects Against Acute Lung Injury After Intestinal Ischemia-Reperfusion in Mice via NF-.BPathway
Akihisa Matsuda et al.
ANNALS OF SURGERY (2014)
On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
Iris Gehrke et al.
CLINICAL CANCER RESEARCH (2014)
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice
Alessio Nencioni et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis
Marie-Charlotte Laiguillon et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Nicotinamide Phosphoribosyltransferase as a Target in Inflammation-Related Disorders
Fabrizio Montecucco et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis?
Mari Nowell et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
Yu-Hung Chang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Adipokines in Periaortic and Epicardial Adipose Tissue: Differential Expression and Relation to Atherosclerosis
Sofia G. Spiroglou et al.
Journal of Atherosclerosis and Thrombosis (2011)
Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity
Susana Vallejo et al.
PLOS ONE (2011)
Visfatin/PBEF and Atherosclerosis-Related Diseases
Theodosios D. Filippatos et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
The autocrine and paracrine roles of adipokines
Kalypso Karastergiou et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Nitric oxide and oxidative stress in vascular disease
Ulrich Foerstermann
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Visfatin causes endothelium-dependent relaxation in isolated blood vessels
Hideyuki Yamawaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide
Pei Wang et al.
CARDIOVASCULAR RESEARCH (2009)
Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
Sheng Wen Liu et al.
CLINICAL ENDOCRINOLOGY (2009)
Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
Mahmut Ilker Yilmaz et al.
CLINICAL TRANSPLANTATION (2009)
Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity
T. Romacho et al.
DIABETOLOGIA (2009)
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis
Raghu Adya et al.
CARDIOVASCULAR RESEARCH (2008)
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
Mahmut Ilker Yilmaz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2
Su-Ryun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians
Sreedharan Sandeep et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus
Kohzo Takebayashi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis -: Possible role in inflammation and plaque destabilization
Tuva B. Dahl et al.
CIRCULATION (2007)
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
Alexander R. Moschen et al.
JOURNAL OF IMMUNOLOGY (2007)
Serum visfatin increases with progressive β-cell deterioration
Abel Lopez-Bermejo et al.
DIABETES (2006)
Endothelial nitric oxide synthase in vascular disease -: From marvel to menace
U Förstermann et al.
CIRCULATION (2006)
An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity
JM Stephens et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
MP Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
J Berndt et al.
DIABETES (2005)
Adipokines: molecular links between obesity and atheroslcerosis
DCW Lau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
分享论文
